Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
VRX | Valeant Pharmaceuticals International, Inc. | Loberg Philip Walden Jr | EVP, Interim CFO | Jun 09, 2011 | Buy | $52.82 | 7,500 | 396,150 | 137,565 | Jun 13, 2011, 02:52 PM |